Abstract
JC virus (JCV) is a human neurotropic polyomavirus that causes the fatal demyelinating disease of the central nervous system known as progressive multifocal leukoencephalopathy (PML). JCV was first isolated in 1971 from the brain tissue of a patient suffering from PML. With the emergence of AIDS in the 1980s, the incidence of PML increased dramatically. There has been a rapid expansion in the number of the additional human polyomaviruses in recent years, due to new discoveries, bringing the present number to 13. In his chapter, a particular attention was devoted to the description of the molecular biology of JCV (section “The Molecular Biology of JCV”) and the pathophysiology of PML (section “The Pathology and Pathogenesis of Progressive Multifocal Leukoencephalopathy”) with special emphasis on exciting aspects of current research into this increasingly important pathogen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed S, Chowdhury M, Khalili K (1990a) Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region. Nucleic Acids Res 18(24):7417–7423
Ahmed S, Rappaport J, Tada H, Kerr D, Khalili K (1990b) A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. J Biol Chem 265(23):13899–13905
Aksamit AJ Jr (1995) Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech 32(4):302–311. doi:10.1002/jemt.1070320405
Aksamit AJ, Gendelman HE, Orenstein JM, Pezeshkpour GH (1990) AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 40(7):1073–1078
Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998) Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12(10):1149–1154
Ali SH, DeCaprio JA (2001) Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 11(1):15–23
Amemiya K, Traub R, Durham L, Major EO (1989) Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264(12):7025–7032
Amemiya K, Traub R, Durham L, Major EO (1992) Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. J Biol Chem 267(20):14204–14211
Amundson SA, Myers TG, Fornace AJ Jr (1998) Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17(25):3287–3299
Anderson HA, Chen Y, Norkin LC (1996) Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 7(11):1825–1834
Astrom KE, Mancell EL, Richardson EPJ (1958) Progressive multifocal encephalopathy: a hitharto unrecognized complication of chronic lymphocytic leukemia and lymphoma. Brain 81:99–111
Atwood JW (2001) Cellular receptors for the polyomaviruses. In: Khalili K, Stoner GL (eds) Human polyomaviruses: molecular and clinical perspectives. Wiley, New York, pp 179–198
Atwood WJ, Amemiya K, Traub R, Harms J, Major EO (1992) Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190(2):716–723
Aurelian L (2005) HSV-induced apoptosis in herpes encephalitis. Curr Top Microbiol Immunol 289:79–111
Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M (2006) BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577:319–341. doi:10.1007/0-387-32957-9_23
Bartt RE (2006) Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy. Curr Opin Neurol 19(4):341–349
Baserga R (2005) The insulin-like growth factor-I receptor as a target for cancer therapy. Expert Opin Ther Targets 9(4):753–768
Beggs AH, Frisque RJ, Scangos GA (1988) Extinction of JC virus tumor-antigen expression in glial cell—fibroblast hybrids. Proc Natl Acad Sci U S A 85(20):7632–7636
Bellizzi A, Anzivino E, Rodio DM, Palamara AT, Nencioni L, Pietropaolo V (2013) New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy. Clin Dev Immunol 2013:839719. doi:10.1155/2013/839719
Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1(1):5–18
Berger JR, Koralnik IJ (2005) Progressive multifocal leukoencephalopathy and natalizumab—unforeseen consequences. N Engl J Med 353(4):414–416
Berger JR, Major EO (1999) Progressive multifocal leukoencephalopathy. Semin Neurol 19(2):193–200
Berger JR, Pall L, Lanska D, Whiteman M (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4(1):59–68
Berger JR, Chauhan A, Galey D, Nath A (2001) Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol 7(4):329–338
Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH (2010) Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 84(4):2150–2156
Bofill-Mas S, Pina S, Girones R (2000) Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 66(1):238–245
Bofill-Mas S, Clemente-Casares P, Major EO, Curfman B, Girones R (2003) Analysis of the excreted JC virus strains and their potential oral transmission. J Neurovirol 9(4):498–507
Boldorini R, Caldarelli-Stefano R, Monga G, Zocchi M, Mediati M, Tosoni A, Ferrante P (1998) PCR detection of JC virus DNA in the brain tissue of a 9-year-old child with pleomorphic xanthoastrocytoma. J Neurovirol 4(2):242–245
Bollag B, Prins C, Snyder EL, Frisque RJ (2000) Purified JC virus T and T′ proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 274(1):165–178
Bollag B, Hofstetter CA, Reviriego-Mendoza MM, Frisque RJ (2010) JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLoS One 5(5), e10606
Borowiec JA, Dean FB, Bullock PA, Hurwitz J (1990) Binding and unwinding—how T antigen engages the SV40 origin of DNA replication. Cell 60(2):181–184
Butel JS (2000) Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21(3):405–426
Butel JS, Lednicky JA (1999) Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91(2):119–134
Butel JS, Arrington AS, Wong C, Lednicky JA, Finegold MJ (1999) Molecular evidence of simian virus 40 infections in children. J Infect Dis 180(3):884–887
Carbone M, Lewis AM Jr, Matthews BJ, Levine AS, Dixon K (1989) Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas. Cancer Res 49(6):1565–1571
Chalkley JJ, Berger JR (2013) Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep 13(12):408. doi:10.1007/s11910-013-0408-6
Chaudhuri A (2006) Selective adhesion-molecule therapy and inflammatory bowel disease. N Engl J Med 354(6):644–645; author reply 644–645
Chen W, Hahn WC (2003) SV40 early region oncoproteins and human cell transformation. Histol Histopathol 18(2):541–550
Chen NN, Chang CF, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili K (1995) Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci U S A 92(4):1087–1091
Choi YW, Lee IC, Ross SR (1988) Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice. Mol Cell Biol 8(8):3382–3390
Chowdhury M, Taylor JP, Tada H, Rappaport J, Wong-Staal F, Amini S, Khalili K (1990) Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 5(12):1737–1742
Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K (1992) Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66(12):7355–7361
Chowdhury M, Kundu M, Khalili K (1993) GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 8(4):887–892
Clever J, Dean DA, Kasamatsu H (1993) Identification of a DNA binding domain in simian virus 40 capsid proteins Vp2 and Vp3. J Biol Chem 268(28):20877–20883
Coleman DV, Wolfendale MR, Daniel RA, Dhanjal NK, Gardner SD, Gibson PE, Field AM (1980) A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 142(1):1–8
Coric P, Saribas AS, Abou-Gharbia M, Childers W, White MK, Bouaziz S, Safak M (2014) Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an alpha-helix encompassing the Leu/Ile/Phe-Rich domain. J Virol 88(12):6556–6575
Cullen BR (1990) The HIV-1 tat protein: as RNA specific processivity factor. Cell 63:655–657
Daniels R, Rusan NM, Wadsworth P, Hebert DN (2006) SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER. Mol Cell 24(6):955–966
Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A, Khalili K (2002) Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 21(36):5574–5581. doi:10.1038/sj.onc.1205744
Del Valle L, Pina-Oviedo S (2006) HIV disorders of the brain: pathology and pathogenesis. Front Biosci 11:718–732
Del Valle L, Croul S, Morgello S, Amini S, Rappaport J, Khalili K (2000) Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol 6(3):221–228
Del Valle L, Enam S, Lara C, Ortiz-Hidalgo C, Katsetos CD, Khalili K (2002a) Detection of JC polyomavirus DNA sequences and cellular localization of T-antigen and agnoprotein in oligodendrogliomas. Clin Cancer Res 8(11):3332–3340
Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakopoulou M, Katsetos CD, Khalili K (2002b) Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst 94(4):267–273
Del Valle L, White MK, Enam S, Pina Oviedo S, Bromer MQ, Thomas RM, Parkman HP, Khalili K (2005) Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 103(3):516–527. doi:10.1002/cncr.20806
Devireddy LR, Kumar KU, Pater MM, Pater A (2000) BAG-1, a novel Bcl-2-interacting protein, activates expression of human JC virus. J Gen Virol 81(Pt 2):351–357
Dworkin MS, Wan PC, Hanson DL, Jones JL (1999) Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 180(3):621–625
Eash S, Querbes W, Atwood WJ (2004) Infection of vero cells by BK virus is dependent on caveolae. J Virol 78(21):11583–11590
Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA (1996) Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol 16(7):3454–3464
Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306(5700):1380–1383
Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP, Khalili K (2002) Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 62(23):7093–7101
Enting RH, Portegies P (2000) Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. J Neurol 247(2):134–138
Fanning E (1992) Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol 66(3):1289–1293
Fanning E, Knippers R (1992) Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 61:55–85
Feigenbaum L, Khalili K, Major E, Khoury G (1987) Regulation of the host range of human papovavirus JCV. Proc Natl Acad Sci U S A 84(11):3695–3698
Feigenbaum L, Hinrichs SH, Jay G (1992) JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice. J Virol 66(2):1176–1182
Frankel AD, Papo CO (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55(6):1189–1193
Fried M, Prives C (1990) The biology of simian virus 40 and polyoma viruses. J Virol 12:1–16
Frisque RJ (1998) Rearranged and chimaeric primate polyomavirus genomes. Dev Biol Stand 94:103–113
Frisque RJ, White FA (1992) The molecular biology of JC virus, causative agent of progressive multifocal leukoencophalopathy. In: Roose RP (ed) Molecular neurovirology, pathogenesis of viral CNS infections. Humana Press, Totowa, pp 25–158
Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51(2):458–469
Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC, Feramisco JR (1994) Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity. Mol Cell Biol 14(9):6244–6252
Fukita Y, Mizuta TR, Shirozu M, Ozawa K, Shimizu A, Honjo T (1993) The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region. J Biol Chem 268(23):17463–17470
Gaillard S, Fahrbach KM, Parkati R, Rundell K (2001) Overexpression of simian virus 40 small-T antigen blocks centrosome function and mitotic progression in human fibroblasts. J Virol 75(20):9799–9807
Gallia GL, Safak M, Khalili K (1998) Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigen. J Biol Chem 273(49):32662–32669
Gan DD, Reiss K, Carrill T, Del Valle L, Croul S, Giordano A, Fishman P, Khalili K (2001) Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene 20(35):4864–4870
Gardner SD, Feild AM, Colleman DV, Hulme B (1971) New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1:1253–1257
Gee GV, Dugan AS, Tsomaia N, Mierke DF, Atwood WJ (2006) The role of sialic acid in human polyomavirus infections. Glycoconj J 23(1–2):19–26
Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, Berger JR, Ngo L, Koralnik IJ (2011) Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85(14):7256–7263
Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000) Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30(1):95–99
Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA (2002) Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22(7):2111–2123
Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338(19):1345–1351
Hallervorden J (1930) Eigennartige und nicht rubriziebare Prozesse. In: Bumke O (ed) Handbuch der Geiteskranheiten, vol 2, Die Anatomie der Psychosen. Springer, Berlin
Henson JW (1994) Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1. J Biol Chem 269(2):1046–1050
Henson J, Saffer J, Furneaux H (1992) The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32(1):72–77
Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24(1):141–146
Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4(4):451–456
Houff SA, London WT, DiChiro G, Padgett BL, Walker DL, Zu Rhein GM, Sever JL (1983) Neuroradiological studies of JCV-induced astrocytomas in nonhuman primates. Prog Clin Biol Res 105:253–259
Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318(5):301–305
Huang SS, Skolasky RL, Dal Pan GJ, Royal W 3rd, McArthur JC (1998) Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 4(3):324–332
Jiang M, Abend JR, Tsai B, Imperiale MJ (2009) Early events during BK virus entry and disassembly. J Virol 83(3):1350–1358
Johne R, Buck CB, Allander T, Atwood WJ, Garcea RL, Imperiale MJ, Major EO, Ramqvist T, Norkin LC (2011) Taxonomical developments in the family Polyomaviridae. Arch Virol 156(9):1627–1634
Kaniowska D, Kaminski R, Amini S, Radhakrishnan S, Rappaport J, Johnson E, Khalili K, Del Valle L, Darbinyan A (2006) Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J Virol 80(18):9288–9299
Kedar S, Berger JR (2011) The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep 13(4):380–386
Kelly TJ (1988) SV40 DNA replication. J Biol Chem 263:17889–17892
Kenney S, Natarajan V, Salzman NP (1986a) Mapping 5′ termini of JC virus late RNA. J Virol 58(1):216–219
Kenney S, Natarajan V, Selzer G, Salzman NP (1986b) Mapping 5′ termini of JC virus early RNAs. J Virol 58(2):651–654
Kerr D, Khalili K (1991) A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. J Biol Chem 266(24):15876–15881
Kerr DA, Chang CF, Gordon J, Bjornsti MA, Khalili K (1993) Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 196(2):612–618
Kerr D, Chang CF, Chen N, Gallia G, Raj G, Schwartz B, Khalili K (1994) Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68(11):7637–7643
Khalili K, Feigenbaum L, Khoury G (1987) Evidence for a shift in 5′-termini of early viral RNA during the lytic cycle of JC virus. Virology 158(2):469–472
Khalili K, Rappaport J, Khoury G (1988) Nuclear factors in human brain cells bind specifically to the JCV regulatory region. EMBO J 7(4):1205–1210
Kim H-S, Henson JW, Frisque RJ (2001) Transcription and replication in the human polyomaviruses. In: Khalili K, Stoner GL (eds) Human polyomaviruses: molecular and clinical perspectives. Wiley, New York, pp 73–126
Kim J, Woolridge S, Biffi R, Borghi E, Lassak A, Ferrante P, Amini S, Khalili K, Safak M (2003) Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol 77(9):5241–5252
Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353(4):369–374
Kolson DL, Sabnekar P, Baybis M, Crino PB (2004) Gene expression in TUNEL-positive neurons in human immunodeficiency virus-infected brain. J Neurovirol 10(Suppl 1):102–107
Kolzau T, Hansen RS, Zahra D, Reddel RR, Braithwaite AW (1999) Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Oncogene 18(40):5598–5603
Krynska B, Otte J, Franks R, Khalili K, Croul S (1999) Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 18(1):39–46. doi:10.1038/sj.onc.1202278
Kumar KU, Pater A, Pater MM (1993) Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells. J Virol 67(1):572–576
Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR (1999) JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 96(13):7484–7489
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4):375–381
Lashgari MS, Tada H, Amini S, Khalili K (1989) Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology 170(1):292–295
Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K (2002) Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 277(19):17231–17238
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323–331
Li F, Altieri DC (1999) Transcriptional analysis of human survivin gene expression. Biochem J 344(Pt 2):305–311
Li PP, Nakanishi A, Shum D, Sun PC, Salazar AM, Fernandez CF, Chan SW, Kasamatsu H (2001) Simian virus 40 Vp1 DNA-binding domain is functionally separable from the overlapping nuclear localization signal and is required for effective virion formation and full viability. J Virol 75(16):7321–7329
Liu CK, Hope AP, Atwood WJ (1998a) The human polyomavirus, JCV, does not share receptor specificity with SV40 on human glial cells. J Neurovirol 4(1):49–58
Liu CK, Wei G, Atwood WJ (1998b) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2–6)-linked sialic acids. J Virol 72(6):4643–4649
London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M, Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T (1978) Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201(4362):1246–1249
Lynch KJ, Frisque RJ (1990) Identification of critical elements within the JC virus DNA replication origin. J Virol 64(12):5812–5822
Lynch KJ, Frisque RJ (1991) Factors contributing to the restricted DNA replicating activity of JC virus. Virology 180(1):306–317
Lynch KJ, Haggerty S, Frisque RJ (1994) DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 204(2):819–822. doi:10.1006/viro.1994.1600
Macdonald JK, McDonald JW (2006) Natalizumab for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 3, CD006097. doi:10.1002/14651858.CD006097
Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5(1):49–73
Mandl CW, Frisque RJ (1986) Characterization of cells transformed by the human polyomavirus JC virus. J Gen Virol 67(Pt 8):1733–1739
Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16(13):1791–1797
Matsumoto T, Eki T, Hurwitz J (1990) Studies on the initiation and elongation reactions in the simian virus 40 DNA replication system. Proc Natl Acad Sci U S A 87(24):9712–9716
Meyer MA (2006) Natalizumab for relapsing multiple sclerosis. N Engl J Med 354(22):2387–2389; author reply 2387–2389
Miller JR, Barrett RE, Britton CB, Tapper ML, Bahr GS, Bruno PJ, Marquardt MD, Hays AP, McMurtry JG 3rd, Weissman JB, Bruno MS (1982) Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med 307(23):1436–1438
Miller NR, London W, Padgett BL, Walker DL, Wallen WC (1983) The detection of JC viral genome in owl monkey tumors. Prog Clin Biol Res 105:271–288
Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO (1996) JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 70(10):7004–7012
Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998a) Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72(12):9918–9923
Monaco MC, Shin J, Major EO (1998b) JC virus infection in cells from lymphoid tissue. Dev Biol Stand 94:115–122
Monaco MC, Sabath BF, Durham LC, Major EO (2001) JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. J Virol 75(20):9687–9695
Monier R (1986) Transformation by SV40 and polyomaviruses. In: Salzman NP (ed) The polyomaviruses, vol 1. Plenum Press, New York
Murakami Y, Wobbe CR, Weissbach L, Dean FB, Hurwitz J (1986) Role of DNA polymerase alpha and DNA primase in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A 83:2869–2873
Neu U, Stehle T, Atwood WJ (2009) The Polyomaviridae: contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 384(2):389–399
Nunbhakdi-Craig V, Craig L, Machleidt T, Sontag E (2003) Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol 77(5):2807–2818
Okada Y, Suzuki T, Sunden Y, Orba Y, Kose S, Imamoto N, Takahashi H, Tanaka S, Hall WW, Nagashima K, Sawa H (2005) Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep 6(5):452–457
Oppenheim A, Sandalon Z, Peleg A, Shaul O, Nicolis S, Ottolenghi S (1992) A cis-acting DNA signal for encapsidation of simian virus 40. J Virol 66(9):5320–5328
Otlu O, De Simone FI, Otalora YL, Khalili K, Sariyer IK (2014) The agnoprotein of polyomavirus JC is released by infected cells: evidence for Its cellular uptake by uninfected neighboring cells. Virology 468–470:88–95
Padgett BL, Zu Rhein GM, Walker DL, Echroade R, Dessel B (1971) Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1:1257–1260
Pho MT, Ashok A, Atwood WJ (2000) JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 74(5):2288–2292
Pina-Oviedo S, Urbanska K, Radhakrishnan S, Sweet T, Reiss K, Khalili K, Del Valle L (2007) Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol 170(4):1291–1304
Porras A, Bennett J, Howe A, Tokos K, Bouck N, Henglein B, Sathyamangalam S, Thimmapaya B, Rundell K (1996) A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J Virol 70(10):6902–6908
Porras A, Gaillard S, Rundell K (1999) The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts. J Virol 73(4):3102–3107
Prins C, Frisque RJ (2001) JC virus T′ proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells. J Neurovirol 7(3):250–264
Querbes W, O’Hara BA, Williams G, Atwood WJ (2006) Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 80(19):9402–9413
Raj GV, Khalili K (1994) Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines. Mol Cell Biol 14(12):7770–7781
Raj GV, Khalili K (1995) Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213(2):283–291
Raj GV, Safak M, MacDonald GH, Khalili K (1996) Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. J Virol 70(9):5944–5953
Ranganathan PN, Khalili K (1993) The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21(8):1959–1964
Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K, Andrews D (1996) Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A 93(14):7352–7357
Renner K, Leger H, Wegner M (1994) The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc Natl Acad Sci U S A 91(14):6433–6437
Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE, Boland CR (2000) JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 119(5):1228–1235
Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR (2001) Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 75(4):1996–2001
Richardson EP (1961) Progressive multifocal encephalopathy. N Engl J Med 265:815–823
Romagnoli L, Sariyer IK, Tung J, Feliciano M, Sawaya BE, Del Valle L, Ferrante P, Khalili K, Safak M, White MK (2008) Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 375(2):331–341
Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK (2009) Modulation of JC virus transcription by C/EBPbeta. Virus Res 146(1–2):97–106
Rundell K, Parakati R (2001) The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 11(1):5–13
Sadowska B, Barrucco R, Khalili K, Safak M (2003) Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 77(1):665–672
Safak M, Gallia GL, Ansari SA, Khalili K (1999a) Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73(12):10146–10157
Safak M, Gallia GL, Khalili K (1999b) A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. Virology 262(1):178–189
Safak M, Gallia GL, Khalili K (1999c) Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells. Mol Cell Biol 19(4):2712–2723
Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K, Khalili K (2001) Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 75(3):1476–1486
Safak M, Sadowska B, Barrucco R, Khalili K (2002) Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol 76(8):3828–3838
Sami Saribas A, Abou-Gharbia M, Childers W, Sariyer IK, White MK, Safak M (2013) Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts. Virology 443(1):161–176
Saribas AS, Arachea BT, White MK, Viola RE, Safak M (2011) Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function. Virology 420(1):51–65
Saribas AS, White MK, Safak M (2012) JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication. Virology 433(1):12–26. doi:10.1016/j.virol.2012.06.017
Saribas AS, Mun S, Johnson J, El-Hajmoussa M, White MK, Safak M (2014) Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication. Virology 449:1–16
Sariyer IK, Akan I, Palermo V, Gordon J, Khalili K, Safak M (2006) Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol 80(8):3893
Sariyer IK, Khalili K, Safak M (2008) Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology 375(2):464–479
Sariyer IK, Saribas AS, White MK, Safak M (2011) Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol J 8(1):255
Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R, Deisseroth AB (1996) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 23(2):402–403
Shaw P, Bovey R, Tardy S, Sahli R, Sodat B, Costa J (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A 89:4495–4499
Shishido-Hara Y, Hara Y, Larson T, Yasui K, Nagashima K, Stoner GL (2000) Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly. J Virol 74(4):1840–1853
Sock E, Wegner M, Fortunato EA, Grummt F (1993) Large T-antigen and sequences within the regulatory region of JC virus both contribute to the features of JC virus DNA replication. Virology 197(2):537–548
Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M (1993) The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75(5):887–897
Sontag E, Sontag JM, Garcia A (1997) Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J 16(18):5662–5671
Soussi T (1986) DNA-binding properties of the major structural protein of simian virus 40. J Virol 59(3):740–742
Srinivasan A, McClellan AJ, Vartikar J, Marks I, Cantalupo P, Li Y, Whyte P, Rundell K, Brodsky JL, Pipas JM (1997) The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol 17(8):4761–4773
Stang E, Kartenbeck J, Parton RG (1997) Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 8(1):47–57
Suzuki T, Okada Y, Semba S, Orba Y, Yamanouchi S, Endo S, Tanaka S, Fujita T, Kuroda S, Nagashima K, Sawa H (2005) Identification of FEZ1 as a protein that interacts with JC virus agnoprotein and microtubules: role of agnoprotein-induced dissociation of FEZ1 from microtubules in viral propagation. J Biol Chem 280(26):24948–24956
Sweeney BJ, Manji H, Miller RF, Harrison MJ, Gray F, Scaravilli F (1994) Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 57(8):994–997
Tada H, Khalili K (1992) A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J Virol 66(12):6885–6892
Tada H, Lashgari M, Rappaport J, Khalili K (1989) Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. J Virol 63(1):463–466
Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990) Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A 87(9):3479–3483
Taguchi F, Kajioka J, Miyamura T (1982) Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 26(11):1057–1064
Tamura T, Miura M, Ikenaka K, Mikoshiba K (1988) Analysis of transcription control elements of the mouse myelin basic protein gene in HeLa cell extracts: demonstration of a strong NFI-binding motif in the upstream region. Nucleic Acids Res 16(24):11441–11459
Tamura T, Aoyama A, Inoue T, Miura M, Mikoshiba K (1990) A new transcription element in the JC virus enhancer. J Gen Virol 71(Pt 8):1829–1833
Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998) Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 178(6):1816–1820
Tavis JE, Frisque RJ (1991) Altered DNA binding and replication activities of JC virus T-antigen mutants. Virology 183(1):239–250
Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31(4):454–462
Trowbridge PW, Frisque RJ (1995) Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 1(2):195–206
Ugi S, Imamura T, Ricketts W, Olefsky JM (2002) Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol 22(7):2375–2387
Varakis J, ZuRhein GM, Padgett BL, Walker DL (1978) Induction of peripheral neuroblastomas in Syrian hamsters after injection as neonates with JC virus, a human polyoma virus. Cancer Res 38(6):1718–1722
Vaz B, Cinque P, Pickhardt M, Weber T (2000) Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirol 6(5):398–409
Walker DL, Padgett BL (1983) The epidemiology of human polyomaviruses. Prog Clin Biol Res 105:99–106
Walker DL, Padgett BL, ZuRhein GM, Albert AE, Marsh RF (1973) Human papovavirus (JC): induction of brain tumors in hamsters. Science 181(100):674–676
Wegner M, Drolet DW, Rosenfeld MG (1993) Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci U S A 90(10):4743–4747
Weinberg DH, Collins KL, Simancek P, Russo A, Wold MS, Virshup DM, Kelly TJ (1990) Reconstitution of simian virus DNA replicaiton with purified proteins. Proc Natl Acad Sci U S A 87:8692–8696
White MK, Gordon J, Reiss K, Del Valle L, Croul S, Giordano A, Darbinyan A, Khalili K (2005) Human polyomaviruses and brain tumors. Brain Res Brain Res Rev 50(1):69–85
White MK, Skowronska A, Gordon J, Del Valle L, Deshmane SL, Giordano A, Khalili K (2006) Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. Anticancer Res 26(6B):4079–4092
White MK, Gordon J, Khalili K (2013) The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog 9(3), e1003206
Winklhofer KF, Albrecht I, Wegner M, Heilbronn R (2000) Human cytomegalovirus immediate-early gene 2 expression leads to JCV replication in nonpermissive cells via transcriptional activation of JCV T antigen. Virology 275(2):323–334
Wollebo HS, Safak M, Del Valle L, Khalili K, White MK (2011) Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 233(1–2):46–53. doi:10.1016/j.jneuroim.2010.11.013
Wollebo HS, Melis S, Khalili K, Safak M, White MK (2012) Cooperative roles of NF-kappaB and NFAT4 in polyomavirus JC regulation at the KB control element. Virology 432(1):146–154
Wollebo HS, Woldemichaele B, Khalili K, Safak M, White MK (2013) Epigenetic regulation of polyomavirus JC. Virol J 10:264
Wright PE, Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 293(2):321–331
Wright PE, Dyson HJ (2014) Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol 16(1):18–29
Yang CS, Vitto MJ, Busby SA, Garcia BA, Kesler CT, Gioeli D, Shabanowitz J, Hunt DF, Rundell K, Brautigan DL, Paschal BM (2005) Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor. Mol Cell Biol 25(4):1298–1308
Yogo Y, Matsushima-Ohno T, Hayashi T, Sugimoto C, Sakurai M, Kanazawa I (2001) JC virus regulatory region rearrangements in the brain of a long surviving patient with progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 71(3):397–400
Yuan H, Veldman T, Rundell K, Schlegel R (2002) Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 76(21):10685–10691
Zhao JJ, Gjoerup OV, Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC (2003) Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3(5):483–495
Zoltick PW, Mayreddy RP, Chang CF, Northrup B, Khalili K, Schwartzman RJ (1995) Isolation and characterization of a type II JC virus from a brain biopsy of a patient with PML. J Neurovirol 1(3–4):307–315
ZuRhein G, Chou SM (1965) Particules resembling papovavirions in human cerebral demyelinating disease. Science 148:1477–1479
Acknowledgement
We would like to thank to the Luis Del Valle for his help with the figures.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
White, M.K., Safak, M. (2016). Molecular Biology of JC Virus and the Human Demyelinating Disease, Progressive Multifocal Leukoencephalopathy. In: Reiss, C. (eds) Neurotropic Viral Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-33189-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-33189-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33188-1
Online ISBN: 978-3-319-33189-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)